Video: Superheroes, Secret Identities & You| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: exercise

Existing CT Scans as Good as DXA for Assessing Hip Fracture Risk

Scott Baltic  |  May 8, 2018

NEW YORK (Reuters Health)—A “biomechanical” analysis of a previously taken pelvic or abdominal computed tomography (CT) scan is at least as accurate in assessing an individual’s hip fracture risk as a dual-energy X-ray absorptiometry (DXA) scan, according to new research. This accuracy of the hip bone mineral density (BMD) T-score as measured by the biomechanical…

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:computed tomographyCT scanOsteoporosisscan

Social Media Connects, Informs Rheumatologists

Linda Childers  |  April 26, 2018

When Paul Sufka, MD, a rheumatologist with HealthPartners Medical Group and Regions Hospital in St. Paul, Minn., wants to connect with his colleagues or keep abreast of the latest rheumatology journal articles, he turns to Twitter. Dr. Sufka is one of many rheumatologists who have found effective ways to incorporate social media into their medical…

Filed under:Education & Training Tagged with:communicationSocial MediaTwitter

New Study Examines the Physical Activity & Joint Symptom Risk

Elizabeth Hofheinz, MPH, MEd  |  April 26, 2018

If you’re a middle-aged woman who makes a New Year’s resolution to work out regularly and you keep that promise for only six months, don’t think that will go far in protecting your joints. Researchers in Australia have homed in on the details of the sustained physical activity required to reduce the risk of joint…

Filed under:Rheumatoid Arthritis Tagged with:BMIHormone Therapyjointsmenopausephysical activity

Study Finds Pedometers Reduce Fatigue in RA Patients

Mary Beth Nierengarten  |  April 26, 2018

For people with rheumatoid arthritis (RA), fatigue can be a debilitating symptom that interferes with daily life and significantly reduces quality of life. Managing fatigue can be difficult; it is linked to disease activity and a host of other conditions that commonly accompany RA, such as depression, sleep problems and obesity. A new study, however,…

Filed under:Rheumatoid Arthritis Tagged with:fatiguepedometersphysical activityRheumatoid arthritis

Using Ultrasound to Diagnose Carpal Tunnel Syndrome

Mark H. Greenberg, MD, RMSK, RhMSUS, Julian Greer, & James W. Fant Jr., MD  |  April 26, 2018

Note: Updated May 2, 2018, to correct a link in the reference section. The error was introduced in editing. A 44-year-old Caucasian woman presented to the outpatient rheumatology clinic that had followed her for several years for rheumatoid arthritis. She was compliant with her regimen of hydroxychloroquine, etanercept and salsalate. Her chief complaint was worsening…

Filed under:ConditionsSoft Tissue Pain Tagged with:Carpal Tunnel Syndromecase reportelectrophysiological studiesUltrasound

ENDANGART / shutterstock.com

Looking Back on 40 Years with Rheumatoid Arthritis

Sarah Troxell, RN, BSN  |  April 26, 2018

The year was 1978. I was a newly married, 25-year-old registered nurse working on a medical unit at Mercy Medical Center in Oshkosh, Wis. I began to notice morning stiffness, increasing fatigue, and bilateral heel and ankle pain. Every step hurt as I walked down the halls to care for my patients. My diagnosis was…

Filed under:Patient Perspective Tagged with:Rheumatoid arthritisSarah Troxell

Cyclophosphamide for Connective Tissue Disease-Associated Interstitial Lung Disease

Lara C. Pullen, PhD  |  April 9, 2018

A recent systematic review found no clear evidence that rheumatoid arthritis patients treated with cyclophosphamide have better lung function than those treated with mycophenolate mofetil. The researchers caution that physicians should expect treatment with cyclophosphamide may only result in a modest improvement in the preservation of forced vital capacity…

Filed under:ConditionsRheumatoid Arthritis Tagged with:cyclophosphamideInterstitial Lung Diseaselunglung diseaselungsrespiratory

Denosumab Boosts BMD after Teriparatide Treatment for Osteoporosis

Marilynn Larkin  |  March 28, 2018

NEW YORK (Reuters Health)—After discontinuation of teriparatide, increases in bone mineral density (BMD) are greater with denosumab than with zoledronic acid, but whether that translates into a decreased fragility fracture risk remains unknown, researchers say. Teriparatide was the first anabolic treatment approved for osteoporosis in the U.S. It has been shown to increase BMD, and…

Filed under:ConditionsDrug UpdatesOsteoarthritis and Bone Disorders Tagged with:bone mineral density (BMD)denosumabOsteoporosisosteoporosis treatmentsteriparatide treatment for osteoporosis

Dermatology Patients on Corticosteroids May Not Receive Osteoporosis Screenings; Plus FDA Approves ZTLido

Michele B. Kaufman, PharmD, BCGP  |  March 28, 2018

A recent study found that dermatology patients taking long-term steroids are not always evaluated for steroid-induced osteoporosis…

Filed under:AnalgesicsConditionsDrug UpdatesOsteoarthritis and Bone Disorders Tagged with:CorticosteroidsDermatologyFDAOsteoporosisPainSteroidsU.S. Food and Drug Administration (FDA)ZTLido

Professor Shares Findings from 45 Years of Lupus Research

Susan Bernstein  |  March 18, 2018

SAN DIEGO—What are the predisposing genes that suggest who will develop active systemic lupus erythematosus and who will stay healthy? Decades of research data help rheumatologists clarify this picture, says Argyrios N. Theofilopoulos, MD, professor of immunology and microbiology at Scripps Research Institute in La Jolla, Calif. At his Nov. 5 lecture at the 2017…

Filed under:Meeting ReportsSystemic Lupus Erythematosus Tagged with:ACR/ARHP Annual MeetingLupusPathogenesisSLE

  • « Previous Page
  • 1
  • …
  • 31
  • 32
  • 33
  • 34
  • 35
  • …
  • 76
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences